Etzer Darout
Stock Analyst at Barclays
(4.96)
# 102
Out of 4,495 analysts
490
Total ratings
64.5%
Success rate
31.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Etzer Darout
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TRAX First Tracks Biotherapeutics | Maintained: Buy | $40 | $32.40 | +23.46% | 3 | Jul 10, 2026 | |
| TVRD Tvardi Therapeutics | Maintained: Sell | $3 | $3.80 | -21.05% | 6 | Jul 8, 2026 | |
| ABVX ABIVAX Société Anonyme | Maintained: Buy | $148 | $140.74 | +5.16% | 11 | Jun 30, 2026 | |
| INCY Incyte | Maintained: Buy | $117 | $118.52 | -1.28% | 15 | Jun 29, 2026 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $125 | $104.50 | +19.62% | 7 | Jun 29, 2026 | |
| CCCC C4 Therapeutics | Maintained: Buy | $7 | $4.29 | +63.17% | 29 | Jun 22, 2026 | |
| SRRK Scholar Rock Holding | Maintained: Buy | $55 | $57.94 | -5.07% | 19 | Jun 18, 2026 | |
| XNCR Xencor | Maintained: Buy | $27 | $16.12 | +67.55% | 30 | Jun 16, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $409 | $302.83 | +35.06% | 7 | Jun 15, 2026 | |
| LEGN Legend Biotech | Maintained: Buy | $80 | $27.38 | +192.18% | 9 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $152 → $124 | $123.83 | +0.14% | 24 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $12.08 | +131.79% | 11 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $8.54 | +134.19% | 35 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $4.37 | +151.72% | 10 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 | $15.48 | +16.28% | 9 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $10.34 | +190.14% | 10 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $234 → $253 | $246.91 | +2.47% | 5 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $27 | $20.75 | +30.12% | 6 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $16.20 | +72.84% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $160 | $88.27 | +81.26% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $4.57 | +31.29% | 33 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 → $75 | $66.59 | +12.63% | 9 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $48 | $38.98 | +23.14% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $3.96 | +304.55% | 30 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $14 | $16.75 | -16.42% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 | $57.10 | -21.19% | 32 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $119 | $137.64 | -13.54% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $37 | $24.84 | +48.95% | 12 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $119 | $119.00 | - | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $4.53 | n/a | 1 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 → $143 | $92.98 | n/a | 10 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $154.62 | n/a | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.11 | n/a | 16 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.59 | n/a | 4 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $29.78 | n/a | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $24.69 | n/a | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.01 | n/a | 7 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.05 | n/a | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $63 | $0.5814 | n/a | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 2,445 → kr 2,612 | $1,888.98 | n/a | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $37 | $127.70 | n/a | 2 | Sep 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $0.6751 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.000001 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $25 | $7.71 | n/a | 2 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $4.20 | n/a | 2 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €22.71 → €26.21 | $3.92 | n/a | 2 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $162 | $312.79 | n/a | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $27.07 | n/a | 4 | Jul 14, 2020 |
First Tracks Biotherapeutics
Jul 10, 2026
Maintained: Buy
Price Target: $40
Current: $32.40
Upside: +23.46%
Tvardi Therapeutics
Jul 8, 2026
Maintained: Sell
Price Target: $3
Current: $3.80
Upside: -21.05%
ABIVAX Société Anonyme
Jun 30, 2026
Maintained: Buy
Price Target: $148
Current: $140.74
Upside: +5.16%
Incyte
Jun 29, 2026
Maintained: Buy
Price Target: $117
Current: $118.52
Upside: -1.28%
Monopar Therapeutics
Jun 29, 2026
Maintained: Buy
Price Target: $125
Current: $104.50
Upside: +19.62%
C4 Therapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $7
Current: $4.29
Upside: +63.17%
Scholar Rock Holding
Jun 18, 2026
Maintained: Buy
Price Target: $55
Current: $57.94
Upside: -5.07%
Xencor
Jun 16, 2026
Maintained: Buy
Price Target: $27
Current: $16.12
Upside: +67.55%
BeOne Medicines AG
Jun 15, 2026
Maintained: Buy
Price Target: $409
Current: $302.83
Upside: +35.06%
Legend Biotech
Jun 15, 2026
Maintained: Buy
Price Target: $80
Current: $27.38
Upside: +192.18%
Jun 9, 2026
Downgraded: Hold
Price Target: $152 → $124
Current: $123.83
Upside: +0.14%
Jun 4, 2026
Maintained: Buy
Price Target: $28
Current: $12.08
Upside: +131.79%
Jun 3, 2026
Maintained: Buy
Price Target: $20
Current: $8.54
Upside: +134.19%
Jun 2, 2026
Maintained: Buy
Price Target: $11
Current: $4.37
Upside: +151.72%
Jun 2, 2026
Maintained: Hold
Price Target: $18
Current: $15.48
Upside: +16.28%
Jun 1, 2026
Maintained: Buy
Price Target: $30
Current: $10.34
Upside: +190.14%
May 27, 2026
Reiterated: Buy
Price Target: $234 → $253
Current: $246.91
Upside: +2.47%
May 20, 2026
Maintained: Buy
Price Target: $21 → $27
Current: $20.75
Upside: +30.12%
May 15, 2026
Maintained: Buy
Price Target: $28
Current: $16.20
Upside: +72.84%
May 13, 2026
Rated: Buy
Price Target: $160
Current: $88.27
Upside: +81.26%
May 13, 2026
Rated: Buy
Price Target: $6
Current: $4.57
Upside: +31.29%
May 13, 2026
Rated: Buy
Price Target: $63 → $75
Current: $66.59
Upside: +12.63%
May 8, 2026
Rated: Buy
Price Target: $45 → $48
Current: $38.98
Upside: +23.14%
May 8, 2026
Rated: Buy
Price Target: $16
Current: $3.96
Upside: +304.55%
May 8, 2026
Rated: Sell
Price Target: $14
Current: $16.75
Upside: -16.42%
May 6, 2026
Maintained: Hold
Price Target: $45
Current: $57.10
Upside: -21.19%
May 6, 2026
Maintained: Buy
Price Target: $119
Current: $137.64
Upside: -13.54%
May 1, 2026
Maintained: Buy
Price Target: $35 → $37
Current: $24.84
Upside: +48.95%
Dec 8, 2025
Maintained: Buy
Price Target: $70 → $119
Current: $119.00
Upside: -
Apr 4, 2025
Maintained: Buy
Price Target: $9
Current: $4.53
Upside: n/a
Mar 11, 2025
Maintained: Buy
Price Target: $130 → $143
Current: $92.98
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $154.62
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $3.11
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $12.59
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $29.78
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $24.69
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $6.01
Upside: n/a
Mar 4, 2025
Rated: Hold
Price Target: n/a
Current: $2.05
Upside: n/a
Feb 27, 2025
Initiated Coverage: Buy
Price Target: $63
Current: $0.5814
Upside: n/a
Aug 11, 2022
Maintained: Hold
Price Target: kr 2,445 → kr 2,612
Current: $1,888.98
Upside: n/a
Sep 13, 2021
Maintained: Buy
Price Target: $38 → $37
Current: $127.70
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $60
Current: $0.6751
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Mar 17, 2021
Maintained: Buy
Price Target: $16 → $25
Current: $7.71
Upside: n/a
Mar 11, 2021
Reiterated: Buy
Price Target: $50 → $48
Current: $4.20
Upside: n/a
Mar 5, 2021
Maintained: Buy
Price Target: €22.71 → €26.21
Current: $3.92
Upside: n/a
Feb 22, 2021
Downgraded: Hold
Price Target: $162
Current: $312.79
Upside: n/a
Jul 14, 2020
Maintained: Buy
Price Target: $48
Current: $27.07
Upside: n/a